<DOC>
	<DOC>NCT02753985</DOC>
	<brief_summary>This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of subjects is 64 (32 patients and 32 partners). The primary method of data collection will be face-to-face semi-structured interviews. These interviews will be audio-recorded.</brief_summary>
	<brief_title>Adherence to Aromatase Inhibitors: The Role of Partners</brief_title>
	<detailed_description />
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Women and partners of women with stage IIII breast cancer who 1. have completed primary cancer treatments (surgery, chemotherapy, radiotherapy) 2. have experienced AI side effects 3. live with a romantic partner.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>